Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...
RPM International Inc. today said that outstanding performance in the company's consumer segment and more modest gains in its industrial segment resulted in significant increases in sales, net income and diluted earnings per share for the ...
Tags: RPM, Financial Position
Synta Pharmaceuticals, a US-based biopharmaceutical company, has named Dr Sumant Ramachandra as the new president of research and development (R&D). Dr Ramachandra served as senior vice president, R&D, regulatory and medical affairs, and ...
Tags: Synta Pharma, biopharmaceutical company, biopharmaceutical
RPM International Inc.through its Rust-Oleum Group has acquired Synta Inc.,a producer and marketer of exterior wood deck and concrete restoration systems.Based in Clarkston,GA,Synta's annual sales are anticipated to exceed$40 million in the ...
Tags: RPM, Synta, concrete restoration systems, exterior wood deck